JP Patent

JP2013049690A — 短時間作用型ベンゾジアゼピンの塩およびそれらの多形形態

Assigned to Paion UK Ltd · Expires 2013-03-14 · 13y expired

What this patent protects

【課題】鎮静または催眠、不安緩解、筋弛緩、または抗痙攣の目的のための薬剤としての短時間作用型ベンゾジアゼピンの塩の提供。【解決手段】下記式で表されるベンゾジアゼピンのベシル酸塩。【選択図】図７

USPTO Abstract

【課題】鎮静または催眠、不安緩解、筋弛緩、または抗痙攣の目的のための薬剤としての短時間作用型ベンゾジアゼピンの塩の提供。【解決手段】下記式で表されるベンゾジアゼピンのベシル酸塩。【選択図】図７

Drugs covered by this patent

remimazolam-besylate (REMIMAZOLAM BESYLATE)

Patent Metadata

Patent number: JP2013049690A
Jurisdiction: JP
Classification: —
Expires: 2013-03-14
Drug substance claim: No
Drug product claim: No
Assignee: Paion UK Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.